Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival

被引：30

作者：

Galleu, Antonio ^{[1
,2
]}

Milojkovic, Dragana ^{[3
]}

Deplano, Simona ^{[3
]}

Szydlo, Richard ^{[4
]}

Loaiza, Sandra ^{[3
]}

Wynn, Robert ^{[5
]}

Marks, David I. ^{[6
]}

Richardson, Deborah ^{[7
]}

Orchard, Kim ^{[7
]}

Kanfer, Edward ^{[3
]}

Tholouli, Eleni ^{[5
]}

Saif, Muhammad ^{[5
]}

Sivaprakasam, Ponni ^{[6
]}

Lawson, Sarah ^{[8
]}

Bloor, Adrian ^{[9
]}

Pagliuca, Antonio ^{[10
]}

Potter, Victoria ^{[10
]}

Mehra, Varun ^{[10
]}

Snowden, John A. ^{[11
]}

Vora, Ajay ^{[12
]}

Kishore, Bhuvan ^{[13
]}

Hunter, Hannah ^{[14
]}

Apperley, Jane F. ^{[3
,4
]}

Dazzi, Francesco ^{[1
,2
,3
,4
]}

机构：

[1] Kings Coll London, London, England

[2] Kings Hlth Partners Canc Res UK Ctr, London, England

[3] Imperial Coll Healthcare NHS Trust, London, England

[4] Imperial Coll London, London, England

[5] Cent Manchester Univ Hosp, Manchester, Lancs, England

[6] Univ Hosp Bristol, Bristol, Avon, England

[7] Southampton Univ Hosp, Southampton, Hants, England

[8] Birmingham Womens & Childrens Hosp, Birmingham, W Midlands, England

[9] Christie NHS Fdn Trust, Manchester, Lancs, England

[10] Kings Coll Hosp NHS Trust, London, England

[11] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

[12] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England

[13] NHS Fdn Trust, Heart England, Birmingham, W Midlands, England

[14] Plymouth Hosp NHS Trust, Plymouth, Devon, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 01期

关键词：

cellular therapies; GvHD; mesenchymal cells; clinical research; stromal cells; STEM-CELLS; STEROID-RESISTANT; ACUTE GVHD; GRADE III; THERAPY;

D O I：

10.1111/bjh.15749

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Mesenchymal stromal cells (MSCs) have been successfully used for the treatment of steroid-resistant graft-versus-host-disease (GvHD). However, the lack of early predictors of clinical responses impacts on the time at which to add further treatment and consequently the design of informative clinical trials. Here, we present the UK experience of one of the largest cohorts of GvHD patients undergoing MSC infusions so far reported. We show that clinical responses assessed as early as 1 week after MSC infusion predict patients' overall survival. In our cohort, cell dose, patients' age and type of organ involvement are crucial factors associated with clinical responses.

引用

页码：89 / 92

页数：4

共 50 条

[31] Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
Stenger, Elizabeth
Giver, Cynthia R.
Langston, Amelia
Kota, Daniel
Das, Pankoj Kumar
Chinnadurai, Raghavan
Galipeau, Jacques
Waller, Edmund K.
Qayed, Muna
FRONTIERS IN IMMUNOLOGY, 2022, 13
[32] Sca1+ mesenchymal stromal cells inhibit graft-versus-host disease in mice after bone marrow transplantation
Wen, Fan
Zhang, Hui-Jie
Chen, Yaozhen
Yue, Qiaohong
Liu, Zheng
Zhang, Qingping
An, Ning
Chen, Xiaopeng
Li, Na
Xin, Jiajia
Wang, Yazhou
Zhang, Xianqing
Xu, Xueqing
Hu, Xingbin
INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 26 (01) : 50 - 57
[33] Treatment and management of graft-versus-host disease: improving response and survival
Garnett, Catherine
Apperley, Jane F.
Pavlu, Jiri
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (06) : 366 - 378
[34] Treatment with Mesenchymal Stromal Cells Overexpressing Fas-Ligand Ameliorates Acute Graft-versus-Host Disease in Mice
Vacaru, Andrei Mircea
Mazilu, Ana-Maria
Dumitrescu, Madalina
Fenyo, Ioana Madalina
Gafencu, Anca Violeta
Vacaru, Ana-Maria
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
[35] The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature
Munneke, J. Marius
Spruit, Melchior J. A.
Cornelissen, Anne S.
van Hoeven, Vera
Voermans, Carlijn
Hazenberg, Mette D.
TRANSPLANTATION, 2016, 100 (11) : 2309 - 2314
[36] The efficiency of human umbilical cord mesenchymal stem cells as a salvage treatment for steroid-refractory acute graft-versus-host disease
Ding, Yihan
Liu, Chang
Cai, Yiming
Hou, Chang
Chen, Guanghua
Xu, Yang
Hu, Shaoyan
Wu, Depei
CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2561 - 2570
[37] Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease-friends or foes?
Balan, A.
Lucchini, G.
Schmidt, S.
Schneider, A.
Tramsen, L.
Kuci, S.
Meisel, R.
Bader, P.
Lehrnbecher, T.
LEUKEMIA, 2014, 28 (10) : 1941 - 1948
[38] The Therapeutic Effect of ICAM 1 Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease
Tang, Bo
Li, Xue
Liu, Yuanlin
Chen, Xiuhui
Li, Ximei
Chu, Yanan
Zhu, Heng
Liu, Weijiang
Xu, Fenfen
Zhou, Fan
Zhang, Yi
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 46 (06) : 2624 - 2635
[39] An early-biomarker algorithm predicts lethal graft-versus-host disease and survival
Hartwell, Matthew J.
Ozbek, Umut
Holler, Ernst
Renteria, Anne S.
Major-Monfried, Hannah
Reddy, Pavan
Aziz, Mina
Hogan, William J.
Ayuk, Francis
Efebera, Yvonne A.
Hexner, Elizabeth O.
Bunworasate, Udomsak
Qayed, Muna
Ordemann, Rainer
Wolfl, Matthias
Mielke, Stephan
Pawarode, Attaphol
Chen, Yi-Bin
Devine, Steven
Harris, Andrew C.
Jagasia, Madan
Kitko, Carrie L.
Litzow, Mark R.
Kroeger, Nicolaus
Locatelli, Franco
Morales, George
Nakamura, Ryotaro
Reshef, Ran
Roesler, Wolf
Weber, Daniela
Wudhikarn, Kitsada
Yanik, Gregory A.
Levine, John E.
Ferrara, James L. M.
JCI INSIGHT, 2017, 2 (03):
[40] Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages
Ringden, O.
Le Blanc, K.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2011, 24 (01) : 65 - 72

← 1 2 3 4 5 →